Home Overview Press Room Blog Publications For Students about us
Search

When is a racial pharmacy bad medicine?

Genetic Crossroads
August 4th, 2006

Do certain medications work better in some races due to their genetic make-up? Though the link between race, genes, and drug response has yet to be proven, markets are starting to develop around the idea that racially tailored therapies are going to be an important part of medicine's future. CGS' Osagie Obasogie and UC Berkeley Bioethics Professor David Winickoff take a critical look at these developments in an article published on the Bioethics Forum. They suggest ways for federal regulators to grapple with the pros and cons of the "racial pharmacy."

Click here to read the full article.

ESPAÑOL | PORTUGUÊS | Русский

home | overview | blog | publications| about us | donate | newsletter | press room | privacy policy

CGS • 1122 University Ave, Suite 100, Berkeley, CA 94702 • • (p) 1.510.665.7760 • (F) 1.510.665.8760